MedTrace Logo

Cataract Surgery Technique and Ocular Clarity

NCT05489198 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-08-05

No results posted yet for this study

Summary

The goal of this study is to study the restoration of quality of vision, expressed as straylight, in the immediate period after cataract surgery with two different phacoemulsification technologies.

Conditions

  • Cataract

Interventions

PROCEDURE

cataract surgery with Centurion phacoemulsification system

Cataract surgery performed with the Centurion phacoemulsification system

PROCEDURE

cataract surgery with Quatera 700 phacoemulsification system

Cataract surgery performed with the Quatera 700 phacoemulsification system

Sponsors & Collaborators

  • Amphia Hospital

    lead OTHER

Principal Investigators

  • Nic J. Reus, MD, PhD · Amphia Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-09-30
Completion
2023-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05489198 on ClinicalTrials.gov